Given the ability of 1 to induce TNFα-TNFR1-dependent cell death signalling, we hypothesised that treatment with sub-toxic concentrations of 1 (50 nM) would sensitize glioblastoma cells to treatment with TNFα. The gene discussed is TNF; the disease is glioblastoma.